TITLE

Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system

AUTHOR(S)
Girlanda, P; Vita, G; Nicolosi, C; Milone, S; Messina, C
PUB. DATE
September 1992
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep1992, Vol. 55 Issue 9, p844
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66072008

 

Related Articles

  • Botulinum neurotoxin type A in neurology: update. Orsini, Marco; Araujo Leite, Marco Antonio; Tae Mo Chung; Bocca, Wladimir; Alves de Souza, Jano; Gameiro de Souza, Olivia; Moreira, Rayele Priscila; Hugo Bastos, Victor; Teixeira, Silmar; Bulle Oliveira, Acary; da Silva Moraes, Bruno; Palma Matta, André; Jacinto, Luis Jorge // Neurology International;2015, Vol. 7 Issue 2, p31 

    This paper reviews the current and most neurological (central nervous system, CNS) uses of the botulinum neurotoxin type A. The effect of these toxins at neuromuscular junction lends themselves to neurological diseases of muscle overactivity, particularly abnormalities of muscle control. There...

  • Botulinum neurotoxin type A in neurology: update. Orsini, Marco; Araujo Leite, Marco Antonio; Tae Mo Chung; Bocca, Wladimir; de Souza, Jano Alves; de Souza, Olivia Gameiro; Moreira, Rayele Priscila; Bastos, Victor Hugo; Teixeira, Silmar; Oliveira, Acary Bulle; da Silva Moraes, Bruno; Matta, André Palma; Jacinto, Luis Jorge // Neurology International;2015, Vol. 7 Issue 3, p31 

    This paper reviews the current and most neurological (central nervous system, CNS) uses of the botulinum neurotoxin type A. The effect of these toxins at neuromuscular junction lends themselves to neurological diseases of muscle overactivity, particularly abnormalities of muscle control. There...

  • Botulinum Toxin Reduced AF Burden, Heart Rate Variability at 1 Year in Pilot Study. Mosley, Mary; Steinberg, Jonathan S. // MD Conference Express;Jun2015, Vol. 15 Issue 12, p10 

    Secondary analysis of a small pilot study has shown that botulinum toxin vs placebo reduces the burden of atrial fibrillation at 1 year after coronary artery bypass graft surgery. An improvement in heart rate variability also suggests that botulinum toxin injected into fat pads is a...

  • Gastrointestinal Smooth Muscles and Sphincters Spasms: Treatment with Botulinum Neurotoxin. G. Brisinda; I.M. Civello; A. Albanese; G. Maria // Current Medicinal Chemistry;Apr2003, Vol. 10 Issue 7, p603 

    More than fifty years following the discovery that botulinum neurotoxins inhibit neuromuscular transmission, these powerful poisons have become drugs with many indications. First used to treat strabismus, local injections of botulinum neurotoxin are now considered a safe and efficacious...

  • Current Clinical Applications of Botulinum Toxin. Truong, Daniel D.; Stenner, Andrea; Reichel, Gerhard // Current Pharmaceutical Design;11/1/2009, Vol. 15 Issue 31, p3671 

    Botulinum toxin has long been known for its paralytic effects on the human voluntary musculature via inhibition of acetylcholine release at neuromuscular junctions. Its original clinical use for the treatment of strabismus has expanded significantly to include neurological conditions related to...

  • Botulinum Toxin for Pain. Casale, Roberto; Tugnoli, Valeria // Drugs in R&D;2008, Vol. 9 Issue 1, p11 

    Botulinum toxin (BTX) injection is being increasingly used ‘off label’ in the management of chronic pain. Data support the hypothesis of a direct analgesic effect of BTX, different to that exerted on muscle. Although the pain-reducing effect of BTX is mainly due to its ability to...

  • Toxina botulínica para la secreción descontrolada de saliva: Presentación de un caso. DI NASSO, Patricia; BACCO RODRIGUEZ, José Luis; MANSILLA MONTENEGRO, Julio // Revista de la Facultad de Odontología. Universidad Nacional de ;2010, Vol. 4 Issue 1, p39 

    The botulinum neurotoxin is produced by the anaerobic bacterium clostridium botulinum (BoNT). It blocks neuromuscular transmission and for this reason it's used to treat diseases with muscular hyperactivity by blocking acetylcholine release and thus synaptic transmission at the neuromuscular...

  • Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy. Keir, James; Giele, Henk P. // Hand Therapy;Jun2009, Vol. 14 Issue 2, p32 

    Introduction. This article reviews the mechanism of action of botulinum toxin and provides an overview of its use in hand disorders relevant to hand therapy such as hyperhidrosis, spasticity, dystonia, tremor, Parkinson's, obstetrical brachial plexus palsy, flexor tendon rehabilitation, lateral...

  • REHABILITACIJA DJECE SA CEREBRALNOM PARALIZOM (BOTULINUM TOXIN). Meholjić-Fetahović, Ajša // Medical Journal;jan-jun2007, Vol. 13 Issue 1/2, p58 

    Botulinum toxin is a natural purified protein and one of the strongest biological poisons -- neurotoksin. It is produced by the bacterium Clostridium botulinum. As it affects neuromuscular bond it also affects one of the symptoms of cerebral palsy -- spasticity. Decreasing the spasticity of...

  • The effects of equinatoxin II on respiration – possible mechanism of the toxin lethality. Bunc, Matja&zbreve;; Frange&zbreve;, Robert; Rozman, Janez; Šuput, Dušan // Pflugers Archiv European Journal of Physiology;Apr2000, Vol. 439 Issue 7, pr129 

    In rat an intravenous application (i.v.) of a lethal dose of the equinatoxin II (EqT II) provoked a respiratory arrest. It is not known whether the respiratory arrest is a result of a direct actions of the toxin on lung tissue, on neuromuscular junctions or the on the central nervous system. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics